Chief Operating Officer, Vaxxas
| Role | Organisation | Sources |
|---|---|---|
| Ellume Health | Brandon Capital portfolio, Brandon BioCatalyst portfolio | |
| Chief Operating Officer | Vaxxas | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Scott Fry. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vaxxas has begun a phase one trial in Australia of its needle-free COVID-19 vaccine patch. The Brisbane company, backed by OneVentures, Brandon Capital and others, has hired Scott Fry from Ellume as COO.
Brisbane biotech Vaxxas has begun human testing of its microneedle patch for COVID-19 vaccination and plans a phase two study; the venture-backed company has raised over $66 million.